Supported medications
Track every major GLP-1
- Weekly · 0.25 – 2.4 mg
Semaglutide
Ozempic · Wegovy
- Weekly · 2.5 – 15 mg
Tirzepatide
Mounjaro · Zepbound
- Daily · 0.6 – 3.0 mg
Liraglutide
Saxenda · Victoza
- Per care plan · Per prescription
Compounded
Custom formulations
Inside the app
How Ampulix tracks your GLP-1




What is Ampulix?
Ampulix is a medication tracking app built for people who manage weekly or daily injection protocols. It gives you a complete, organized record of every dose you take — what was administered, when, where, and at what amount.
Whether you are managing a long-term GLP-1 program, cycling through different dose tiers, or coordinating multiple medications, Ampulix keeps everything in one place and makes it easy to share a clear record with your care team.
The app is designed for people who want more than a notes app or spreadsheet. Ampulix builds a structured, timestamped ledger that you can review at any time and export as a PDF for your provider.
Which GLP-1 medications does Ampulix track?
Ampulix supports all major GLP-1 and GLP-1/GIP medications. You can configure any of the following:
Ozempic (semaglutide) — weekly subcutaneous injection, 0.25 mg to 2 mg. Used for type 2 diabetes management and commonly prescribed off-label for weight management.
Wegovy (semaglutide) — weekly subcutaneous injection, 2.4 mg. FDA-approved specifically for chronic weight management in adults with obesity or weight-related conditions.
Mounjaro (tirzepatide) — weekly subcutaneous injection, 2.5 mg to 15 mg. A dual GLP-1/GIP receptor agonist approved for type 2 diabetes with significant weight effects.
Zepbound (tirzepatide) — weekly subcutaneous injection, 2.5 mg to 15 mg. The same molecule as Mounjaro, approved specifically for chronic weight management.
Saxenda (liraglutide) — daily subcutaneous injection, titrated from 0.6 mg to 3.0 mg. Approved for chronic weight management; requires daily injection unlike weekly semaglutide or tirzepatide options.
Victoza (liraglutide) — daily subcutaneous injection, 0.6 mg to 1.8 mg. FDA-approved for type 2 diabetes management.
Ampulix also supports compounded semaglutide and tirzepatide, generic formulations, and any other injectable medication you want to track. You name the compound and configure the dose — Ampulix handles the rest.
How does Ampulix help with GLP-1 tracking?
Dose logging with an immutable ledger
Every dose you log is permanently recorded with a timestamp and the exact amount administered. Ampulix uses a soft-void system — if you need to correct an entry, the original log is retained and marked as voided. You always have a complete, accurate history.
Injection site rotation
Rotating injection sites reduces scar tissue and improves absorption. Ampulix includes a human body diagram where you tap to record your injection site after each dose. The app shows you where you last injected and prompts you to rotate to a new site next time.
Common injection sites for GLP-1 medications — abdomen, thigh, deltoid — are all supported. Ampulix remembers your history across all sites so you can rotate systematically.
Smart reminders
Ampulix sends push notifications and email reminders on your scheduled injection day. For weekly medications like Ozempic, Wegovy, Mounjaro, and Zepbound, the app knows your day of the week and will not send a reminder if you have already logged a dose.
Reminders are cycling-aware and skip days you do not need to inject. You can configure the notification method per protocol.
Dose escalation tracking
GLP-1 programs typically start at a low dose and escalate over several months. Each time you update your dose in Ampulix, your historical logs continue to record the actual dose administered at that time. You get a clear picture of your full escalation history, not just your current dose.
Vial supply tracking
When you open a new pen or vial, log it and tell Ampulix how many doses it holds. As you log injections, Ampulix counts the supply down and projects the date it will run out from your weekly schedule. Set a reorder lead time and Ampulix raises a Low Supply alert that far ahead — so for compounded GLP-1s that ship from a pharmacy on a lead time, the prompt to reorder arrives before your current pen is empty. The Today screen surfaces every protocol running low in one place.
PDF export for your provider
Ampulix generates a clean PDF report of your complete dose history — every entry, every date, every injection site, with dose amounts. Bring it to your provider visit or share it with your care team without having to reconstruct your history from memory.
What is included in the free trial?
The free trial gives you 7 days of full access to all Ampulix features with no credit card required. You can:
- Add as many medications as you need
- Log doses, injection sites, and notes
- Set up push and email reminders
- Access your complete dose history
- Export PDF reports
- Use AI label scanning to add a medication from a photo of its packaging or care plan
After 7 days, plans start at $9.99 per month or $79.99 per year (saving 33% compared to monthly).
How do injection site rotation and dose tracking work?
When you add a medication to Ampulix, you choose the injection sites you use for that protocol. Each time you log a dose, you tap the site on the body diagram where you injected.
Ampulix records each site log with a timestamp. The next time you open the app, you can see at a glance where you last injected and which site is next in rotation. For subcutaneous injections like GLP-1 medications, systematic rotation across the abdomen, thighs, and other sites is important for consistent absorption and tissue health.
The dose log records the exact amount for each entry. This is especially useful during escalation periods — you can see exactly what dose you were on each week as you titrated up, which is useful context for provider visits and for understanding your own response to different dose levels.
All logs are timestamped and retained permanently. Nothing is ever deleted. If you need to void a log, the original entry remains in your history with a voided flag, and a new corrected entry is added.